A detailed history of Cwm, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Cwm, LLC holds 21,261 shares of DGX stock, worth $2.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,261
Previous 19,641 8.25%
Holding current value
$2.91 Million
Previous $2.69 Million 22.81%
% of portfolio
0.01%
Previous 0.01%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$137.09 - $137.09 $222,085 - $222,085
1,620 Added 8.25%
21,261 $3.3 Million
Q2 2024

Jul 09, 2024

BUY
$125.91 - $144.34 $68,495 - $78,520
544 Added 2.85%
19,641 $2.69 Million
Q1 2024

Apr 05, 2024

BUY
$123.78 - $142.11 $111,030 - $127,472
897 Added 4.93%
19,097 $2.54 Million
Q4 2023

Feb 01, 2024

BUY
$120.62 - $141.12 $27,983 - $32,739
232 Added 1.29%
18,200 $2.51 Million
Q3 2023

Oct 11, 2023

BUY
$121.86 - $144.92 $1.62 Million - $1.93 Million
13,284 Added 283.6%
17,968 $2.19 Million
Q2 2023

Aug 03, 2023

BUY
$130.56 - $146.84 $45,173 - $50,806
346 Added 7.98%
4,684 $658,000
Q1 2023

Apr 28, 2023

BUY
$131.53 - $155.76 $85,099 - $100,776
647 Added 17.53%
4,338 $614,000
Q4 2022

Feb 01, 2023

BUY
$123.31 - $157.26 $21,702 - $27,677
176 Added 5.01%
3,691 $577,000
Q3 2022

Oct 27, 2022

SELL
$121.77 - $141.1 $34,095 - $39,508
-280 Reduced 7.38%
3,515 $431,000
Q2 2022

Jul 28, 2022

BUY
$127.07 - $145.39 $69,253 - $79,237
545 Added 16.77%
3,795 $505,000
Q1 2022

Apr 21, 2022

BUY
$129.09 - $164.35 $155,037 - $197,384
1,201 Added 58.61%
3,250 $445,000
Q4 2021

Jan 31, 2022

BUY
$140.36 - $173.01 $208,996 - $257,611
1,489 Added 265.89%
2,049 $355,000
Q1 2021

Sep 15, 2021

BUY
$114.63 - $133.34 $9,170 - $10,667
80 Added 16.67%
560 $74,000
Q1 2021

Apr 27, 2021

SELL
$114.63 - $133.34 $9,170 - $10,667
-80 Reduced 14.29%
480 $62,000
Q4 2020

Sep 15, 2021

SELL
$112.7 - $128.05 $13,073 - $14,853
-116 Reduced 17.16%
560 $74,000
Q4 2020

Jan 27, 2021

BUY
$112.7 - $128.05 $13,073 - $14,853
116 Added 20.71%
676 $81,000
Q3 2020

Sep 15, 2021

SELL
$107.05 - $130.01 $53,632 - $65,135
-501 Reduced 47.22%
560 $74,000
Q3 2020

Oct 19, 2020

BUY
$107.05 - $130.01 $53,632 - $65,135
501 Added 89.46%
1,061 $121,000
Q2 2020

Sep 15, 2021

SELL
$73.34 - $122.61 $88,228 - $147,499
-1,203 Reduced 68.24%
560 $74,000
Q2 2020

Jul 22, 2020

BUY
$73.34 - $122.61 $88,228 - $147,499
1,203 Added 214.82%
1,763 $201,000
Q1 2020

Sep 15, 2021

SELL
$75.14 - $115.68 $7.25 Million - $11.2 Million
-96,482 Reduced 99.42%
560 $74,000
Q1 2020

Apr 28, 2020

BUY
$75.14 - $115.68 $7.25 Million - $11.2 Million
96,482 Added 17228.93%
97,042 $7.79 Million
Q4 2019

Sep 14, 2021

SELL
$100.29 - $107.99 $54,557 - $58,746
-544 Reduced 49.28%
560 $74,000
Q4 2019

Jan 27, 2020

BUY
$100.29 - $107.99 $54,557 - $58,746
544 Added 97.14%
1,104 $118,000
Q3 2019

Sep 14, 2021

BUY
$97.85 - $107.42 $26,615 - $29,218
272 Added 94.44%
560 $74,000
Q3 2019

Oct 22, 2019

SELL
$97.85 - $107.42 $26,615 - $29,218
-272 Reduced 48.57%
288 $31,000
Q2 2019

Sep 14, 2021

BUY
$85.18 - $101.94 $8,177 - $9,786
96 Added 20.69%
560 $74,000
Q2 2019

Jul 31, 2019

SELL
$85.18 - $101.94 $8,177 - $9,786
-96 Reduced 17.14%
464 $47,000
Q1 2019

Sep 02, 2021

BUY
$80.68 - $89.92 $21,944 - $24,458
272 Added 94.44%
560 $0
Q1 2019

Apr 22, 2019

SELL
$80.68 - $89.92 $3,791 - $4,226
-47 Reduced 14.03%
288 $26,000
Q4 2018

Jan 25, 2019

BUY
$79.75 - $108.38 $4,625 - $6,286
58 Added 20.94%
335 $28,000
Q3 2018

Oct 29, 2018

BUY
$105.42 - $114.99 $8,117 - $8,854
77 Added 38.5%
277 $30,000
Q1 2018

Apr 26, 2018

SELL
$96.42 - $107.88 $8,967 - $10,032
-93 Reduced 31.74%
200 $20,000
Q4 2017

Jan 16, 2018

SELL
$90.86 - $100.24 $636 - $701
-7 Reduced 2.33%
293 $29,000
Q3 2017

Oct 16, 2017

BUY
$91.96 - $108.35 $27,587 - $32,505
300
300 $28,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.